• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hong Kong: Caritas Medical Centre reports Vancomycin Resistant Enterococci cases (10/14/10)

Giuseppe

Emeritus
Hong Kong: Caritas Medical Centre reports Vancomycin Resistant Enterococci cases (10/14/10)


[Source: Hospital Authority, Hong Kong PRC SAR, View Original Article.]

The following is issued on behalf of the Hospital Authority:

The spokesperson of Caritas Medical Centre (CMC) made the following announcement today (October 14) :

A 84-year-old female patient of a medical ward in CMC was confirmed of urinary tract infection of Vancomycin Resistant Enterococci (VRE) onOctober 9.

To act in accordance with the prevailing infection control guidelines, the hospital has quarantined the patients who have stayed in the same cubicle with the index patients and performed screening tests for them.

Subsequently, three more female patients (aged 85 to 89) were identified as VRE carriers.

One of the carriers died from her underlying illness
on October 12.

The three in-patients are now placed under isolation and their conditions are stable.

The hospital has stepped up the infection control measures according to existing procedures.

Follow-up screenings for a total of 31 patients who have been under close monitoring have been arranged and the results are pending.

There are clinical guidelines in public hospitals to ensure proper use of antibiotics, including Vancomycin, and management of VRE carriers.

The cases have been reported to the Hospital Authority Head Office and the Centre for Health Protection for follow up.
-
------
 
Back
Top Bottom